CAMBRIDGE, Mass., Jan. 16 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated will announce its fourth quarter and full year 2006 financial results on Thursday, February 1, 2007 after the financial markets close. The Company will host a conference call at 5:00 p.m. EST.
The conference call will be webcast live and may be accessed from the 'Events Calendar' of Vertex's website at www.vrtx.com. A replay of the conference call and webcast will be archived on the Company's website until February 15, 2007. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and bacterial infection. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
Vertex's press releases are available at www.vrtx.com. Vertex Contact: Lora Pike, Manager, Investor Relations, (617)-444-6755
Vertex Pharmaceuticals IncorporatedCONTACT: Lora Pike, Manager, Investor Relations of Vertex PharmaceuticalsIncorporated, +1-617-444-6755
Web site: http://www.vrtx.com//
Company News On-Call: http://www.prnewswire.com/comp/938395.html/
